Search

Your search keyword '"Vassal, G."' showing total 775 results

Search Constraints

Start Over You searched for: Author "Vassal, G." Remove constraint Author: "Vassal, G."
775 results on '"Vassal, G."'

Search Results

1. Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program

2. Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed

6. Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

8. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

10. Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children.

14. Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

15. INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY

17. Intercontinental collaboration in clinical trials for children and adolescents with cancer—A systematic review by ACCELERATE

18. Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours

19. 464P Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset

20. IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma

21. 468P Real-world safety of trametinib monotherapy or in combination with dabrafenib in children, adolescents, and young adults with relapsed or refractory low-grade glioma (LGG) and high-grade glioma (HGG)

26. A European paediatric cancer mission: aspiration or reality?

28. Access to essential anticancer medicines for children and adolescents in Europe

34. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children

35. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

37. Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network

38. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

39. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

47. 604TiP ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer

48. 542P Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients

Catalog

Books, media, physical & digital resources